Literature DB >> 29885329

CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool.

Carolyn Brokowski1, Mazhar Adli2.   

Abstract

With the emergence of CRISPR technology, targeted editing of a wide variety of genomes is no longer an abstract hypothetical, but occurs regularly. As application areas of CRISPR are exceeding beyond research and biomedical therapies, new and existing ethical concerns abound throughout the global community about the appropriate scope of the systems' use. Here we review fundamental ethical issues including the following: 1) the extent to which CRISPR use should be permitted; 2) access to CRISPR applications; 3) whether a regulatory framework(s) for clinical research involving human subjects might accommodate all types of human genome editing, including editing of the germline; and 4) whether international regulations governing inappropriate CRISPR utilization should be crafted and publicized. We conclude that moral decision making should evolve as the science of genomic engineering advances and hold that it would be reasonable for national and supranational legislatures to consider evidence-based regulation of certain CRISPR applications for the betterment of human health and progress.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRISPR–Cas9; bioengineering; genetic engineering; genome editing; research ethics

Mesh:

Year:  2018        PMID: 29885329      PMCID: PMC6286228          DOI: 10.1016/j.jmb.2018.05.044

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   6.151


  131 in total

1.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Authors:  Lars M Bjorklund; Rosario Sánchez-Pernaute; Sangmi Chung; Therese Andersson; Iris Yin Ching Chen; Kevin St P McNaught; Anna-Liisa Brownell; Bruce G Jenkins; Claes Wahlestedt; Kwang-Soo Kim; Ole Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

2.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.

Authors:  Ganesh Suntharalingam; Meghan R Perry; Stephen Ward; Stephen J Brett; Andrew Castello-Cortes; Michael D Brunner; Nicki Panoskaltsis
Journal:  N Engl J Med       Date:  2006-08-14       Impact factor: 91.245

3.  Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing.

Authors:  Patricio Atanes; Inmaculada Ruz-Maldonado; Ross Hawkes; Bo Liu; Shanta J Persaud; Stefan Amisten
Journal:  Cell Physiol Biochem       Date:  2018-01-31

4.  Using CRISPR-based gene drive for agriculture pest control.

Authors:  Virginie Courtier-Orgogozo; Baptiste Morizot; Christophe Boëte
Journal:  EMBO Rep       Date:  2017-08-07       Impact factor: 8.807

5.  CRISPR gene-editing tested in a person for the first time.

Authors:  David Cyranoski
Journal:  Nature       Date:  2016-11-24       Impact factor: 49.962

Review 6.  Key elements for designing and performing a CRISPR/Cas9-based genetic screen.

Authors:  Wanjing Shang; Fei Wang; Gaofeng Fan; Haopeng Wang
Journal:  J Genet Genomics       Date:  2017-09-22       Impact factor: 4.275

7.  Editing the human genome: balancing safety and regulation.

Authors: 
Journal:  Lancet       Date:  2018-02-03       Impact factor: 79.321

8.  Investigation of the cause of death in a gene-therapy trial.

Authors:  Karen M Frank; D Kyle Hogarth; Jonathan L Miller; Saptarshi Mandal; Philip J Mease; R Jude Samulski; Glen A Weisgerber; John Hart
Journal:  N Engl J Med       Date:  2009-07-09       Impact factor: 91.245

9.  RNA targeting with CRISPR-Cas13.

Authors:  Omar O Abudayyeh; Jonathan S Gootenberg; Patrick Essletzbichler; Shuo Han; Julia Joung; Joseph J Belanto; Vanessa Verdine; David B T Cox; Max J Kellner; Aviv Regev; Eric S Lander; Daniel F Voytas; Alice Y Ting; Feng Zhang
Journal:  Nature       Date:  2017-10-04       Impact factor: 49.962

10.  CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells.

Authors:  Chaogang Wei; Fengjiao Wang; Wei Liu; Wenlu Zhao; Yi Yang; Kai Li; Li Xiao; Junkang Shen
Journal:  Mol Med Rep       Date:  2017-12-12       Impact factor: 2.952

View more
  29 in total

1.  The ecology and evolution of microbial CRISPR-Cas adaptive immune systems.

Authors:  Edze R Westra; Stineke van Houte; Sylvain Gandon; Rachel Whitaker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

Review 2.  Enhancing the Therapeutic Potential of Mesenchymal Stem Cells with the CRISPR-Cas System.

Authors:  Daniel Mendes Filho; Patrícia de Carvalho Ribeiro; Lucas Felipe Oliveira; Ana Luiza Romero Terra Dos Santos; Ricardo Cambraia Parreira; Mauro Cunha Xavier Pinto; Rodrigo Ribeiro Resende
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

Review 3.  Public health concerns over gene-drive mosquitoes: will future use of gene-drive snails for schistosomiasis control gain increased level of community acceptance?

Authors:  Damilare O Famakinde
Journal:  Pathog Glob Health       Date:  2020-02-26       Impact factor: 2.894

4.  The sparkle of creativity.

Authors:  Patricia A Thistlethwaite
Journal:  J Thorac Cardiovasc Surg       Date:  2020-06-18       Impact factor: 5.209

Review 5.  Recent Advances and Therapeutic Strategies Using CRISPR Genome Editing Technique for the Treatment of Cancer.

Authors:  Shreyasi Maity; Rishyani Mukherjee; Satarupa Banerjee
Journal:  Mol Biotechnol       Date:  2022-08-23       Impact factor: 2.860

6.  CRISPR-Cas9 and He Jiankui's Case: an Islamic Bioethics Review using Maqasid al-Shari'a and Qawaid Fighiyyah.

Authors:  Nimah Alsomali; Ghaiath Hussein
Journal:  Asian Bioeth Rev       Date:  2021-03-20

Review 7.  Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application.

Authors:  Kateryna Kratzer; Landon J Getz; Thibaut Peterlini; Jean-Yves Masson; Graham Dellaire
Journal:  Hum Genet       Date:  2021-04-08       Impact factor: 4.132

8.  Attitudes of Indonesian Medical Doctors and Medical Students Toward Genome Editing.

Authors:  Safira Nur Izzah; Dimas Setyanto; Nurina Hasanatuludhhiyah; Danti Nur Indiastuti; Zamal Nasution; Annette d'Arqom
Journal:  J Multidiscip Healthc       Date:  2021-05-04

Review 9.  CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues.

Authors:  Roberto Piergentili; Alessandro Del Rio; Fabrizio Signore; Federica Umani Ronchi; Enrico Marinelli; Simona Zaami
Journal:  Cells       Date:  2021-04-21       Impact factor: 7.666

Review 10.  New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer.

Authors:  Munazza Ahmed; Grace Hope Daoud; Asmaa Mohamed; Rania Harati
Journal:  Genes (Basel)       Date:  2021-05-12       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.